Author: claimsbot

1. An indeno-fused ring pyran compound represented by the following Formula II,
wherein,
(A) Ring-A is selected from unsubstituted aryl, substituted aryl, unsubstituted fused ring aryl, substituted fused ring aryl, unsubstituted heteroaryl, and substituted heteroaryl;
(B) Q\u2032\u2033 is selected from halogen, \u2014OH, \u2014N3, \u2014NRaRa, \u2014N(Ra)C(O)Q\u2033, \u2014CN, \u2014C(O)ORa, \u2014C(O)Ra, \u2014C\u2261C\u2014Ra, \u2014C(Ra)\u2550C(Ra)(Ra), \u2014OC(O)Ra, \u2014OC(O)ORa, \u2014SRa, \u2014OS(O2)Rb and \u2014C(O)NRaRa, wherein each Ra is independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl each optionally and independently interrupted with at least one of \u2014O\u2014, \u2014S\u2014, \u2014C(O)\u2014, \u2014C(O)O\u2014, \u2014S(O)\u2014, \u2014S(O2)\u2014, \u2014N\u2550N\u2014, \u2014N(R11\u2032)\u2014 where R11\u2032 is selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, \u2014Si(OR14)u(R14)v\u2014, where u and v are each independently selected from 0 to 2, provided that the sum of u and v is 2, and each R14 is independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl, and combinations of two or more thereof, or two Ra groups come together with \u2014N and optionally an additional hetero atom selected from N and O to form a heterocycloalkyl, and Rb is selected from perhalohydrocarbyl, and Q\u2033 is selected from halo, \u2014ORa, \u2014NRaRa, \u2014C(O)ORa, \u2014SRa, and hydrocarbyl or substituted hydrocarbyl wherein said substituents are selected from \u2014OH, \u2014NRaRa, \u2014C(O)ORa, \u2014SRa;
(C) i is selected from 0 to 3, t is selected from 0 to a total number of positions to which R2 can be bonded, and R1 for each i, and R2 for each t, are each independently selected from, hydrocarbyl and substituted hydrocarbyl each optionally and independently interrupted with at least one of \u2014O\u2014, \u2014S\u2014, \u2014C(O)\u2014, \u2014C(O)O\u2014, \u2014S(O)\u2014, \u2014S(O2)\u2014, \u2014N\u2550N\u2014, \u2014N(R11\u2032)\u2014 where R11\u2032 is selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, \u2014Si(OR14)u(R14)v\u2014, where u and v are each independently selected from 0 to 2, provided that the sum of u and v is 2, and each R14 is independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl, and combinations of two or more thereof; halogen; cyano; and \u2014N(R11\u2032)R12\u2032, wherein R11\u2032 and R12\u2032 are each independently selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, or R11\u2032 and R12\u2032 together form a ring structure optionally including at least one heteroatom;
(D) R3 and R4 are each independently selected from, hydrogen; hydrocarbyl and substituted hydrocarbyl each optionally and independently interrupted with at least one of \u2014O\u2014, \u2014S\u2014, \u2014C(O)\u2014, \u2014C(O)O\u2014, \u2014S(O)\u2014, \u2014S(O2)\u2014, \u2014N\u2550N\u2014, \u2014N(R11\u2032)\u2014 where R11\u2032 is selected from hydrogen, hydrocarbyl or substituted hydrocarbyl, \u2014Si(OR14)u(R14)v\u2014, where u and v are each independently selected from 0 to 2, provided that the sum of u and v is 2, and each R14 is independently selected from hydrogen, hydrocarbyl and substituted hydrocarbyl, and combinations of two or more thereof; or R3 and R4 together form a ring structure optionally including at least one heteroatom; and
(E) B and B\u2032 are each independently selected from hydrogen, unsubstituted aryl, substituted aryl, unsubstituted heteroaryl, substituted heteroaryl, polyalkoxy, and polyalkoxy having a polymerizable group, or B and B\u2032 taken together form a ring structure selected from unsubstituted fluoren-9-ylidene, substituted fluoren-9-ylidene, saturated spiro-monocyclic hydrocarbon ring, saturated spiro-bicyclic hydrocarbon ring, and spiro-tricyclic hydrocarbon ring.
2. The indeno-fused ring pyran compound of claim 1, wherein,
(A) Ring-A is selected from unsubstituted aryl and substituted aryl;
(B) for Q\u2032\u2033, each Ra is independently selected from hydrogen, an unsubstituted or substituted alkyl group having from 1 to 18 carbon atoms, an unsubstituted or substituted aryl group, an unsubstituted or substituted alkene or alkyne group having from 2 to 18 carbon atoms, wherein said substituents are chosen from halo and hydroxyl, and Rb is selected from a perfluorinated alkyl group having from 1 to 18 carbon atoms;
(C) Ra for each i, and R2 for each t, are each independently selected from,
(a) \u2014C(O)X24, wherein X24 is chosen from a lengthening agent L, hydroxy, C1-C18 alkyl, C1-C18 alkoxy, phenyl that is unsubstituted or mono-substituted with C1-C18 alkyl or C1-C18 alkoxy, amino that is unsubstituted, mono- or di-substituted with at least one of C1-C18 alkyl, phenyl, benzyl, and naphthyl,
(b) \u2014OX7 and \u2014N(X7)2; wherein X7 is chosen from:
(i) hydrogen, a lengthening agent L, C1-C18 alkyl, C1-C18 acyl, phenyl(C1-C18)alkyl, mono(C1-C18)alkyl substituted phenyl(C1-C18)alkyl, mono(C1-C18)alkoxy substituted phenyl(C1-C18)alkyl; C1-C18 alkoxy(C1-C18)alkyl; C3-C10 cycloalkyl; mono(C1-C18)alkyl substituted C3-C10 cycloalkyl, C1-C18 haloalkyl, allyl, benzoyl, mono-substituted benzoyl, naphthoyl or mono-substituted naphthoyl, wherein each of said benzoyl and naphthoyl substituents are independently chosen from C1-C18 alkyl, and C1-C18 alkoxy,
(ii) \u2014CH(X8)X9, wherein X8 is chosen from hydrogen, a lengthening agent L, or C1-C18 alkyl, and X9 is chosen from a lengthening agent L, \u2014CN, \u2014CF3, or \u2014COOX10, wherein X10 is chosen from hydrogen, a lengthening agent L, or C1-C18 alkyl,
(iii) \u2014C(O)X6, wherein X6 is chosen from at least one of, hydrogen, a lengthening agent L, C1-C18 alkoxy, phenoxy that is unsubstituted, mono- or di-substituted with C1-C18 alkyl or C1-C18 alkoxy, an aryl group that is unsubstituted, mono- or di-substituted with C1-C18 alkyl or C1-C18 alkoxy, an amino group that is unsubstituted, mono- or di-substituted with C1-C18 alkyl, and a phenylamino group that is unsubstituted, mono- or di-substituted with C1-C18 alkyl or C1-C18 alkoxy, or
(iv) tri(C1-C18)alkylsilyl, tri(C1-C18)alkylsilyloxy, tri(C1-C18)alkoxysilyl, tri(C1-C18)alkoxysilyloxy, di(C1-C18)alkyl(C1-C18 alkoxy)silyl, di(C1-C18)alkyl(C1-C18 alkoxy)silyloxy, di(C1-C18)alkoxy(C1-C18 alkyl)silyl or di(C1-C18)alkoxy(C1-C18 alkyl)silyloxy;

(c) \u2014SX11, wherein X11 is chosen from hydrogen, a lengthening agent L, C1-C18 alkyl, C1-C18 haloalkyl, an aryl group that is unsubstituted, or mono- or di-substituted with C1-C18 alkyl, C1-C18 alkoxy, or halogen;
(d) a nitrogen containing ring represented by Formula i:
wherein, each \u2014Y\u2014 is independently chosen for each occurrence from \u2014CH2\u2014, \u2014CH(R13\u2032)\u2014, \u2014C(R13\u2032)2\u2014, \u2014CH(aryl)-, \u2014C(aryl)2-, and \u2014C(R13\u2032)(aryl)-, and Z is \u2014Y\u2014, \u2014O\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014SO2\u2014, \u2014NH\u2014, \u2014N(R13\u2032)\u2014, or \u2014N(aryl)-, wherein each R13\u2032 is independently a lengthening group L, or C1-C20 alkyl, each aryl is independently phenyl or naphthyl, m is an integer 1, 2 or 3, and p is an integer 0, 1, 2, or 3, provided that when p is 0, Z is \u2014Y\u2014;

(e) a group represented by Formula ii or iii,
wherein X14, X15, and X16 are independently chosen for each occurrence from hydrogen, a lengthening agent L, C1-C18 alkyl, phenyl or naphthyl, or X14 and X15 together form a ring of 5 to 8 carbon atoms, p is an integer chosen from 0, 1, or 2, and X17 is independently chosen for each occurrence from a lengthening agent L, C1-C18 alkyl, C1-C18 alkoxy, or halogen;
(f) immediately adjacent R1 groups, and immediately adjacent R2 groups, in each case independently together form a group represented by Formula vii, viii, or ix,
\u2003wherein,
(i) W and W\u2032 are independently chosen for each occurrence from \u2014O\u2014, \u2014N(X7)\u2014, \u2014C(X14)\u2014, and \u2014C(X17)\u2014,
(ii) wherein X14 and X15 are independently chosen for each occurrence from hydrogen, a lengthening agent L, C1-C18 alkyl, phenyl or naphthyl, or X14 and X15 together form a ring of 5 to 8 carbon atoms; and X17 is independently chosen for each occurrence from a lengthening agent L, C1-C18 alkyl, C1-C18 alkoxy, or halogen, and
(iii) q is an integer chosen from 0, 1, 2, 3, and 4;

(g) a lengthening agent L represented by the following formula,
\u2014(S1)c-(Q1-(S2)d)d\u2032-(Q2-(S3)e)e\u2032-(Q3-(S4)f)f\u2032\u2014S5\u2014P
\u2003wherein,
(i) each Q1, Q2, and Q3 is independently chosen for each occurrence from, a divalent group chosen from, an unsubstituted or a substituted aromatic group, an unsubstituted or a substituted alicyclic group, an unsubstituted or a substituted heterocyclic group, and mixtures thereof, wherein substituents are chosen from, a group represented by P, liquid crystal mesogens, halogen, poly(C1-C18 alkoxy), C1-C18 alkoxycarbonyl, C1-C18 alkylcarbonyl, C1-C18 alkoxycarbonyloxy, aryloxycarbonyloxy, perfluoro(C1-C18)alkoxy, perfluoro(C1-C18)alkoxycarbonyl, perfluoro(C1-C18)alkylcarbonyl, perfluoro(C1-C18)alkylamino, di-(perfluoro(C1-C18)alkyl)amino, perfluoro(C1-C18)alkylthio, C1-C18 alkylthio, C1-C18 acetyl, C3-C10 cycloalkyl, C3-C10 cycloalkoxy, a straight-chain or branched C1-C18 alkyl group that is mono-substituted with cyano, halo, or C1-C18 alkoxy, or poly-substituted with halo, and a group comprising one of the following formulae: -M(T)(t-1) and -M(OT)(t-1), wherein M is chosen from aluminum, antimony, tantalum, titanium, zirconium and silicon, T is chosen from organofunctional radicals, organofunctional hydrocarbon radicals, aliphatic hydrocarbon radicals and aromatic hydrocarbon radicals, and t is the valence of M,
(ii) c, d, e, and f are each independently chosen from an integer ranging from 0 to 20, inclusive; and each S1, S2, S3, S4, and S5 is independently chosen for each occurrence from a spacer unit chosen from:
(1) optionally substituted alkylene, optionally substituted haloalkylene, \u2014Si(Z\u2032)2(CH2)g\u2014, and
\u2003wherein each Z\u2032 is independently selected from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl, and aryl; g for each occurrence is independently chosen from an integer from 1 to 20; h for each occurrence is independently chosen from an integer from 1 to 16; and said substituents for the alkylene and haloalkylene are independently selected from C1-C18 alkyl, C3-C10 cycloalkyl and aryl;
(2) \u2014N(Z)\u2014, \u2014C(Z)\u2550C(Z)\u2014, \u2014C(Z)\u2550N\u2014, \u2014C(Z\u2032)2\u2014C(Z\u2032)2\u2014 or a single bond, wherein Z is independently chosen for each occurrence from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl and aryl, and Z\u2032 is independently chosen for each occurrence from C1-C18 alkyl, C3-C10 cycloalkyl and aryl; and
(3) \u2014O\u2014, \u2014C(O)\u2014, \u2014C\u2261C\u2014, \u2014N\u2550N\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014S(O)(O)\u2014, \u2014(O)S(O)\u2014, \u2014(O)S(O)O\u2014, \u2014O(O)S(O)O\u2014, or straight-chain or branched C1-C24 alkylene residue, said C1-C24 alkylene residue being unsubstituted, mono-substituted by cyano or halo, or poly-substituted by halo,

provided that when two spacer units comprising heteroatoms are linked together the spacer units are linked so that heteroatoms are not directly linked to each other, and
provided that when S1 and S5 are linked to Formula II and P, respectively, they are linked so that two heteroatoms are not directly linked to each other;
(iii) P is chosen from: hydroxy, amino, C2-C18 alkenyl, C2-C18 alkynyl, azido, silyl, siloxy, silylhydride, (tetrahydro-2H-pyran-2-yl)oxy, thio, isocyanato, thioisocyanato, acryloyloxy, methacryloyloxy, 2-(acryloyloxy)ethylcarbamyl, 2-(methacryloyloxy)ethylcarbamyl, aziridinyl, allyloxycarbonyloxy, epoxy, carboxylic acid, carboxylic ester, acryloylamino, methacryloylamino, aminocarbonyl, C1-C18 alkyl aminocarbonyl, aminocarbonyl(C1-C18)alkyl, C1-C18 alkyloxycarbonyloxy, halocarbonyl, hydrogen, aryl, hydroxy(C1-C18)alkyl, C1-C18 alkyl, C1-C18 alkoxy, amino(C1-C18)alkyl, C1-C18 alkylamino, di-(C1-C18)alkylamino, C1-C18 alkyl(C1-C18)alkoxy, C1-C18 alkoxy(C1-C18)alkoxy, nitro, poly(C1-C18)alkyl ether, (C1-C18)alkyl(C1-C18)alkoxy(C1-C18)alkyl, polyethyleneoxy, polypropyleneoxy, ethylenyl, acryloyl, acryloyloxy(C1-C18)alkyl, methacryloyl, methacryloyloxy(C1-C18)alkyl, 2-chloroacryloyl, 2-phenylacryloyl, acryloyloxyphenyl, 2-chloroacryloylamino, 2-phenylacryloylaminocarbonyl, oxetanyl, glycidyl, cyano, isocyanato(C1-C18)alkyl, itaconic acid ester, vinyl ether, vinyl ester, a styrene derivative, main-chain and side-chain liquid crystal polymers, siloxane derivatives, ethyleneimine derivatives, maleic acid derivatives, fumaric acid derivatives, unsubstituted cinnamic acid derivatives, cinnamic acid derivatives that are substituted with at least one of methyl, methoxy, cyano and halogen, or substituted or unsubstituted chiral or non-chiral monovalent or divalent groups chosen from steroid radicals, terpenoid radicals, alkaloid radicals and mixtures thereof, wherein the substituents are independently chosen from C1-C18 alkyl, C1-C18 alkoxy, amino, C3-C10 cycloalkyl, C1-C18 alkyl(C1-C18)alkoxy, fluoro(C1-C18)alkyl, cyano, cyano(C1-C18)alkyl, cyano(C1-C18)alkoxy or mixtures thereof, or P is a structure having from 2 to 4 reactive groups or P is an unsubstituted or substituted ring opening metathesis polymerization precursor; and
(iv) d\u2032, e\u2032 and f\u2032 are each independently chosen from 0, 1, 2, 3, and 4, provided that a sum of d\u2032+e\u2032+f\u2032 is at least 1; and

(h) a group B as described hereinafter;

(D) R3 and R4 are each independently selected from,
(i) hydrogen, C1-C20 alkyl, C1-C20 haloalkyl, C3-C10 cycloalkyl, allyl, benzyl, or mono-substituted benzyl, said benzyl substituents being chosen from halogen, C1-C20 alkyl or C1-C20 alkoxy;
(ii) an unsubstituted, mono- di- or tri-substituted group chosen from phenyl, naphthyl, phenanthryl, pyrenyl, quinolyl, isoquinolyl, benzofuranyl, thienyl, benzothienyl, dibenzofuranyl, dibenzothienyl, carbazolyl, or indolyl, said group substituents in each case being independently chosen from halogen, C1-C20 alkyl or C1-C20 alkoxy;
(iii) mono-substituted phenyl, said substituent located at the para position being \u2014(CH2)t\u2014 or \u2014O\u2014(CH2)t\u2014, wherein t is the integer 1, 2, 3, 4, 5 or 6, said substituent being connected to an aryl group which is a member of a photochromic material;
(iv) the group \u2014CH(R10)G, wherein R10 is hydrogen, C1-C20 alkyl or the unsubstituted, mono- or di-substituted aryl groups phenyl or naphthyl, and G is \u2014CH2OR11, wherein R11 is hydrogen, \u2014C(O)R10, C1-C20 alkyl, C1-C20 alkoxy(C1-C20)alkyl, phenyl(C1-C20)alkyl, mono(C1-C20)alkoxy substituted phenyl(C1-C20)alkyl, or the unsubstituted, mono- or di-substituted aryl groups phenyl or naphthyl, each of said phenyl and naphthyl group substituents being C1-C20 alkyl or C1-C20 alkoxy; or
(v) R3 and R4 together form a spiro substituent selected from a substituted or unsubstituted spiro-carbocyclic ring containing 3 to 6 carbon atoms, a substituted or unsubstituted spiro-heterocyclic ring containing 1 or 2 oxygen atoms and 3 to 6 carbon atoms including the spirocarbon atom, said spiro-carbocyclic ring and spiro-heterocyclic ring being annellated with 0, 1 or 2 benzene rings, said substituents being hydrogen or C1-C20 alkyl; and

(E) B and B\u2032 are each independently selected from,
(i) hydrogen, C1-C18 alkyl, C2-C18 alkylidene, C2-C18 alkylidyne, vinyl, C3-C10 cycloalkyl, C1-C18 haloalkyl, allyl, halogen, and benzyl that is unsubstituted or mono-substituted with at least one of C1-C18 alkyl and C1-C18 alkoxy;
(ii) phenyl that is mono-substituted at the para position with at least one substituent chosen from: C1-C18 alkoxy, linear or branched chain C1-C20 alkylene, linear or branched chain C1-C4 polyoxyalkylene, cyclic C3-C20 alkylene, phenylene, naphthylene, C1-C18 alkyl substituted phenylene, mono- or poly-urethane(C1-C20)alkylene, mono- or poly-ester(C1-C20)alkylene, mono- or poly-carbonate(C1-C20)alkylene, polysilanylene, polysiloxanylene and mixtures thereof, wherein the at least one substituent is connected to an aryl group of a photochromic material,
(iii) \u2014CH(CN)2 and \u2014CH(COOX1)2, wherein X1 is chosen from at least one of hydrogen, a lengthening agent L, C1-C18 alkyl that is unsubstituted or mono-substituted with phenyl, phenyl(C1-C18)alkyl that is mono-substituted with C1-C18 alkyl, C1-C18 haloalkyl or C1-C18 alkoxy, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C18 alkyl and C1-C18 alkoxy; and lengthening agent L,
(iv) \u2014CH(X2)(X3), wherein,
(1) X2 is chosen from at least one of hydrogen, a lengthening agent L, C1-C18 alkyl, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C18 alkyl and C1-C18 alkoxy; and
(2) X3 is chosen from at least one of \u2014COOX1, \u2014COX1, \u2014COX4, and \u2014CH2OX5, wherein: X4 is chosen from at least one of morpholino, piperidino, amino that is unsubstituted, mono- or di-substituted with C1-C18 alkyl, and an unsubstituted, mono- or di-substituted group chosen from phenylamino and diphenylamino, wherein each substituent is independently chosen from C1-C18 alkyl or C1-C18 alkoxy; and X5 is chosen from hydrogen, a lengthening agent L, \u2014C(O)X2, C1-C18 alkyl that is unsubstituted or mono-substituted with (C1-C18)alkoxy or phenyl, phenyl(C1-C18)alkyl that is mono-substituted with (C1-C18)alkoxy, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C18, alkyl and C1-C18 alkoxy;
(v) an unsubstituted, mono-, di-, or tri-substituted aryl group; 9-julolidinyl; or an unsubstituted, mono- or di-substituted heteroaromatic group chosen from pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, carbazoyl, benzopyridyl, indolinyl, or fluorenyl; wherein each aryl and heteroaromatic group substituent is independently chosen for each occurrence from:
(1) a lengthening agent L;
(2) \u2014COOX1, or \u2014C(O)X6;
(3) aryl, halogen, haloaryl, C3-C10 cycloalkylaryl, and an aryl group that is mono- or di-substituted with C1-C18 alkyl or C1-C18 alkoxy;
(4) C1-C18 alkyl, C3-C10 cycloalkyl, C3-C10 cycloalkyloxy(C1-C18)alkyl, aryl(C1-C18)alkyl, aryloxy(C1-C18)alkyl, mono- or di-(C1-C18)alkylaryl(C1-C18)alkyl, mono- or di-(C1-C18)alkoxyaryl(C1-C18)alkyl, C1-C18 haloalkyl, and mono(C1-C18)alkoxy(C1-C18)alkyl;
(5) C1-C18 alkoxy, C3-C10 cycloalkoxy, cycloalkyloxy(C1-C18)alkoxy, aryl(C1-C18)alkoxy, aryloxy(C1-C18)alkoxy, mono- or di-(C1-C18)alkylaryl(C1-C18)alkoxy, and mono- or di-(C1-C18)alkoxyaryl(C1-C18)alkoxy;
(6) aminocarbonyl, aminocarbonyl(C1-C18)alkylene, amino, mono- or di-alkylamino, diarylamino, piperazino, N\u2014(C1-C18)alkylpiperazino, N-arylpiperazino, aziridino, indolino, piperidino, morpholino, thiomorpholino, tetrahydroquinolino, tetrahydroisoquinolino, pyrrolidyl, hydroxy, acryloxy, methacryloxy, and halogen;
(7) \u2014OX7 or \u2014N(X7)2;
(8) \u2014SX11;
(9) a nitrogen containing ring represented by Formula i;
(10) a group represented by Formula ii or iii;
(11) an unsubstituted or mono-substituted group chosen from pyrazolyl, imidazolyl, pyrazolinyl, imidazolinyl, pyrrolidinyl, phenothiazinyl, phenoxazinyl, phenazinyl, or acridinyl, wherein each substituent is independently chosen from a lengthening agent L, C1-C18 alkyl, C1-C18 alkoxy, phenyl, hydroxy, amino or halogen;
(12) a group represented by Formula iv or v:
wherein,
(I) V\u2032 is independently chosen in each formula from \u2014O\u2014, \u2014CH\u2014, C1-C6 alkylene, and C3-C10 cycloalkylene,
(II) V is independently chosen in each formula from \u2014O\u2014 or \u2014N(X21)\u2014, wherein X21 is hydrogen, a lengthening agent L, C1-C18 alkyl, and C2-C18 acyl, provided that if V is \u2014N(X21)\u2014, V\u2032 is \u2014CH2\u2014,
(III) X18 and X19 are each independently chosen from hydrogen, a lengthening agent L, and C1-C18 alkyl, and
(IV) k is chosen from 0, 1, and 2, and each X20 is independently chosen for each occurrence from a lengthening agent L, C1-C18 alkyl, C1-C18 alkoxy, hydroxy and halogen; and
(13) a group represented by Formula vi:
wherein
(I) X22 is chosen from hydrogen, a lengthening agent L, and C1-C18 alkyl, and
(II) X23 is chosen from a lengthening agent L and an unsubstituted, mono-, or di-substituted group chosen from naphthyl, phenyl, furanyl and thienyl, wherein each substituent is independently chosen for each occurrence from C1-C18, alkyl, C1-C18 alkoxy, and halogen; and
(vi) B and B\u2032 together form fluoren-9-ylidene, mono- or di-substituted fluoren-9-ylidene, or a saturated C3-C12 spiro-monocyclic hydrocarbon ring, saturated C7-C12 spiro-bicyclic hydrocarbon rings, saturated C7-C12 spiro-tricyclic hydrocarbon rings; and said fluoren-9-ylidene substituents being selected from the group consisting of C1-C4 alkyl, C1-C4 alkoxy, bromo, fluoro and chloro.
3. The indeno-fused ring pyran compound of claim 1, wherein,
(A) Ring-A is selected from unsubstituted aryl and substituted aryl;
(B) for Q\u2032\u2033, each Ra is independently selected from hydrogen and an alkyl group having from 1 to 6 carbon atoms, and Rb is selected from a perfluorinated alkyl group having from 1 to 6 carbon atoms;
(c) R1 for each i, and R2 for each t, are each independently selected from,
(a) \u2014C(O)X24, wherein X24 is chosen from a lengthening agent L, hydroxy, C1-C12 alkyl, C1-C12 alkoxy, phenyl that is unsubstituted or mono-substituted with C1-C6 alkyl or C1-C6 alkoxy, amino that is unsubstituted, mono- or di-substituted with at least one of C1-C6 alkyl, phenyl, benzyl, and naphthyl;
(b) \u2014OX7 and \u2014N(X7)2; wherein X7 is chosen from,
(i) hydrogen, a lengthening agent L, C1-C12 alkyl, C1-C12 acyl, phenyl(C1-C12)alkyl, mono(C1-C12)alkyl substituted phenyl(C1-C12)alkyl, mono(C1-C12)alkoxy substituted phenyl(C1-C12)alkyl; C1-C12 alkoxy(C1-C12)alkyl; C3-C7 cycloalkyl; mono(C1-C12)alkyl substituted C3-C7 cycloalkyl, C1-C12 haloalkyl, allyl, benzoyl, mono-substituted benzoyl, naphthoyl or mono-substituted naphthoyl, wherein each of said benzoyl and naphthoyl substituents are independently chosen from C1-C6 alkyl, and C1-C6 alkoxy;
(ii) \u2014CH(X8)X9, wherein X8 is chosen from hydrogen, a lengthening agent L, or C1-C12 alkyl; and X9 is chosen from a lengthening agent L, \u2014CN, \u2014CF3, or \u2014COOX10, wherein X10 is chosen from hydrogen, a lengthening agent L, or C1-C12 alkyl;
(iii) \u2014C(O)X6, wherein X6 is chosen from at least one of, hydrogen, a lengthening agent L, C1-C12 alkoxy, phenoxy that is unsubstituted, mono- or di-substituted with C1-C12 alkyl or C1-C12 alkoxy, an aryl group that is unsubstituted, mono- or di-substituted with C1-C6 alkyl or C1-C6 alkoxy, an amino group that is unsubstituted, mono- or di-substituted with C1-C6 alkyl, and a phenylamino group that is unsubstituted, mono- or di-substituted with C1-C6 alkyl or C1-C6 alkoxy;

(c) a nitrogen containing ring represented by Formula i;
wherein, each \u2014Y\u2014 is independently chosen for each occurrence from \u2014CH2\u2014, \u2014CH(R13\u2032)\u2014, \u2014C(R13\u2032)2\u2014, \u2014CH(aryl)-, \u2014C(aryl)2-, and \u2014C(R13\u2032)(aryl)-, and Z is \u2014Y\u2014, \u2014O\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014SO2\u2014, \u2014NH\u2014, \u2014N(R13\u2032)\u2014, or \u2014N(aryl)-, wherein each R13\u2032 is independently a lengthening group L, or C1-C20 alkyl, each aryl is independently phenyl or naphthyl, m is an integer 1, 2 or 3, and p is an integer 0, 1, 2, or 3, provided that when p is 0, Z is \u2014Y\u2014;

(d) the group represented by Formula ii or iii;
wherein X14, X15, and X16 are independently chosen for each occurrence from hydrogen, a lengthening agent L, C1-C12 alkyl, phenyl or naphthyl, or X14 and X15 together form a ring of 5 to 7 carbon atoms; p is an integer chosen from 0, 1, or 2, and X17 is independently chosen for each occurrence from a lengthening agent L, C1-C12 alkyl, C1-C12 alkoxy, or halogen;
(e) immediately adjacent R1 groups, and immediately adjacent R2 groups, in each case independently together form a group represented by Formula vii, viii, or ix,
\u2003wherein,
(i) W and W\u2032 are independently chosen for each occurrence from \u2014O\u2014, \u2014N(X7)\u2014, \u2014C(X14)\u2014, and \u2014C(X17)\u2014,
(ii) wherein X14 and X15 are independently chosen for each occurrence from hydrogen, a lengthening agent L, C1-C12 alkyl, phenyl or naphthyl, or X14 and X15 together form a ring of 5 to 7 carbon atoms; and X17 is independently chosen for each occurrence from a lengthening agent L, C1-C12 alkyl, C1-C12 alkoxy, or halogen, and
(iii) q is an integer chosen from 0 to 3;

(f) a lengthening agent L represented by the following formula,
\u2014(S1)c-(Q1-(S2)d)d\u2032-(Q2-(S3)e)e\u2032(Q3-(S4)f)f\u2032\u2014S5\u2014P
\u2003wherein,
(i) each Q1, Q2, and Q3 is independently chosen for each occurrence from, a divalent group chosen from, an unsubstituted or a substituted aromatic group, an unsubstituted or a substituted alicyclic group, an unsubstituted or a substituted heterocyclic group, and mixtures thereof, wherein substituents are chosen from, a group represented by P, liquid crystal mesogens, halogen, poly(C1-C18 alkoxy), C1-C18 alkoxycarbonyl, C1-C18 alkylcarbonyl, C1-C18 alkoxycarbonyloxy, aryloxycarbonyloxy, perfluoro(C1-C18)alkoxy, perfluoro(C1-C18)alkoxycarbonyl, perfluoro(C1-C18)alkylcarbonyl, perfluoro(C1-C18)alkylamino, di-(perfluoro(C1-C18)alkyl)amino, perfluoro(C1-C18)alkylthio, C1-C18 alkylthio, C1-C18 acetyl, C3-C10 cycloalkyl, C3-C10 cycloalkoxy, a straight-chain or branched C1-C18 alkyl group that is mono-substituted with cyano, halo, or C1-C18 alkoxy, or poly-substituted with halo, and a group comprising one of the following formulae: -M(T)(t-1) and -M(OT)(t-1), wherein M is chosen from aluminum, antimony, tantalum, titanium, zirconium and silicon, T is chosen from organofunctional radicals, organofunctional hydrocarbon radicals, aliphatic hydrocarbon radicals and aromatic hydrocarbon radicals, and t is the valence of M,
(ii) c, d, e, and f are each independently chosen from an integer ranging from 0 to 20, inclusive; and each S1, S2, S3, S4, and S5 is independently chosen for each occurrence from a spacer unit chosen from:
(1) \u2014(CH2)g\u2014, \u2014(CF2)h\u2014, \u2014Si(Z\u2032)2(CH2)g\u2014, \u2014(Si(CH3)2O)h\u2014, wherein each Z\u2032 is independently selected from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl, and aryl; g is independently chosen for each occurrence from 1 to 20; h is a whole number from 1 to 16 inclusive;
(2) \u2014N(Z)\u2014, \u2014C(Z)\u2550C(Z)\u2014, \u2014C(Z)\u2550N\u2014, \u2014C(Z\u2032)\u2014C(Z\u2032)\u2014 or a single bond, wherein Z is independently chosen for each occurrence from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl and aryl, and Z\u2032 is independently chosen for each occurrence from C1-C18 alkyl, C3-C10 cycloalkyl and aryl; and
(3) \u2014O\u2014, \u2014C(O)\u2014, \u2014C\u2261C\u2014, \u2014N\u2550N\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014S(O)(O)\u2014, \u2014(O)S(O)\u2014, \u2014(O)S(O)O\u2014, \u2014O(O)S(O)O\u2014, or straight-chain or branched C1-C24 alkylene residue, said C1-C24 alkylene residue being unsubstituted, mono-substituted by cyano or halo, or poly-substituted by halo,

provided that when two spacer units comprising heteroatoms are linked together the spacer units are linked so that heteroatoms are not directly linked to each other, and
provided that when S1 and S5 are linked to Formula II and P, respectively, they are linked so that two heteroatoms are not directly linked to each other;
(iii) P is chosen from: hydroxy, amino, C2-C18 alkenyl, C2-C18 alkynyl, azido, silyl, siloxy, silylhydride, (tetrahydro-2H-pyran-2-yl)oxy, thio, isocyanato, thioisocyanato, acryloyloxy, methacryloyloxy, 2-(acryloyloxy)ethylcarbamyl, 2-(methacryloyloxy)ethylcarbamyl, aziridinyl, allyloxycarbonyloxy, epoxy, carboxylic acid, carboxylic ester, acryloylamino, methacryloylamino, aminocarbonyl, C1-C18 alkyl aminocarbonyl, aminocarbonyl(C1-C18)alkyl, C1-C1A alkyloxycarbonyloxy, halocarbonyl, hydrogen, aryl, hydroxy(C1-C18)alkyl, C1-C18 alkyl, C1-C18 alkoxy, amino(C1-C18)alkyl, C1-C18 alkylamino, di-(C1-C18)alkylamino, C1-C18 alkyl(C1-C18)alkoxy, C1-C18 alkoxy(C1-C18)alkoxy, nitro, poly(C1-C18)alkyl ether, (C1-C18)alkyl(C1-C1)alkoxy(C1-C18)alkyl, polyethyleneoxy, polypropyleneoxy, ethylenyl, acryloyl, acryloyloxy(C1-C18)alkyl, methacryloyl, methacryloyloxy(C1-C18)alkyl, 2-chloroacryloyl, 2-phenylacryloyl, acryloyloxyphenyl, 2-chloroacryloylamino, 2-phenylacryloylaminocarbonyl, oxetanyl, glycidyl, cyano, isocyanato(C1-C18)alkyl, itaconic acid ester, vinyl ether, vinyl ester, a styrene derivative, main-chain and side-chain liquid crystal polymers, siloxane derivatives, ethyleneimine derivatives, maleic acid derivatives, fumaric acid derivatives, unsubstituted cinnamic acid derivatives, cinnamic acid derivatives that are substituted with at least one of methyl, methoxy, cyano and halogen, or substituted or unsubstituted chiral or non-chiral monovalent or divalent groups chosen from steroid radicals, terpenoid radicals, alkaloid radicals and mixtures thereof, wherein the substituents are independently chosen from C1-C18 alkyl, C1-C18 alkoxy, amino, C3-C10 cycloalkyl, C1-C18 alkyl(C1-C18)alkoxy, fluoro(C1-C18)alkyl, cyano, cyano(C1-C18)alkyl, cyano(C1-C18)alkoxy or mixtures thereof, or P is a structure having from 2 to 4 reactive groups or P is an unsubstituted or substituted ring opening metathesis polymerization precursor; and
(iv) d\u2032, e\u2032 and f\u2032 are each independently chosen from 0, 1, 2, 3, and 4, provided that a sum of d\u2032+e\u2032+f\u2032 is at least 1;

(g) a group B as described hereinafter;

(D) R3 and R4 are each independently selected from hydrogen, C1-C8 alkyl, C1-C8 haloalkyl, and C3-C7 cycloalkyl, or R3 and R4 together form a spiro substituent selected from a substituted or unsubstituted spiro-carbocyclic ring containing 3 to 6 carbon atoms; and
(E) B and B\u2032 are each independently selected from,
(i) C1-C12 alkyl, C3-C7 cycloalkyl, C1-C12 haloalkyl and benzyl that is unsubstituted or mono-substituted with at least one of C1-C6 alkyl and C1-C6 alkoxy;
(ii) \u2014CH(CN)2 and \u2014CH(COOX1)2, wherein X1 is chosen from at least one of hydrogen, a lengthening agent L, C1-C12 alkyl that is unsubstituted or mono-substituted with phenyl, phenyl(C1-C6)alkyl that is mono-substituted with C1-C6 alkyl or C1-C6 alkoxy, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C6 alkyl and C1-C6 alkoxy; and lengthening agent L;
(iii) \u2014CH(X2)(X3), wherein,
(1) X2 is chosen from at least one of a lengthening agent L, C1-C12 alkyl, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C6 alkyl and C1-C6 alkoxy; and
(2) X3 is chosen from at least one of \u2014COOX1, \u2014COX1, \u2014COX4, and \u2014CH2OX5, wherein: X4 is chosen from at least one of morpholino, piperidino, amino that is unsubstituted, mono- or di-substituted with C1-C6 alkyl, and an unsubstituted, mono or di-substituted group chosen from phenylamino and diphenylamino, wherein each substituent is independently chosen from C1-C6 alkyl or C1-C6 alkoxy; and X5 is chosen from hydrogen, a lengthening agent L, \u2014C(O)X2, C1-C12 alkyl that is unsubstituted or mono-substituted with (C1-C12)alkoxy or phenyl, phenyl(C1-C12)alkyl that is mono-substituted with (C1-C12)alkoxy, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C6 alkyl and C1-C6 alkoxy;
(iv) an unsubstituted, mono-, di-, or tri-substituted aryl group; 9-julolidinyl; or an unsubstituted, mono- or di-substituted heteroaromatic group chosen from pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, carbazoyl, benzopyridyl, indolinyl, or fluorenyl; wherein each aryl and heteroaromatic group substituent is independently chosen for each occurrence from:
(1) a lengthening agent L;
(2) \u2014COOX1 or \u2014C(O)X6;
(3) aryl, haloaryl, C3-C7 cycloalkylaryl, and an aryl group that is mono- or di-substituted with C1-C12 alkyl or C1-C12 alkoxy;
(4) C1-C12 alkyl, C3-C7 cycloalkyl, C3-C7 cycloalkyloxy(C1-C12)alkyl, aryl(C1-C12)alkyl, aryloxy(C1-C12)alkyl, mono- or di-(C1-C12)alkylaryl(C1-C12)alkyl, mono- or di-(C1-C12)alkoxyaryl(C1-C12)alkyl, haloalkyl, and mono(C1-C12)alkoxy(C1-C12)alkyl;
(5) C1-C12 alkoxy, C3-C7 cycloalkoxy, cycloalkyloxy(C1-C12)alkoxy, aryl(C1-C12)alkoxy, aryloxy(C1-C12)alkoxy, mono- or di-(C1-C12)alkylaryl(C1-C12)alkoxy, and mono- or di-(C1-C12)alkoxyaryl(C1-C12)alkoxy;
(6) amido, amino, mono- or di-alkylamino, diarylamino, piperazino, N\u2014(C1-C18)alkylpiperazino, N-arylpiperazino, aziridino, indolino, piperidino, morpholino, thiomorpholino, tetrahydroquinolino, tetrahydroisoquinolino, pyrrolidyl, hydroxy, acryloxy, methacryloxy, and halogen;
(7) \u2014OX7 or \u2014N(X7)2; and
(8) an unsubstituted or mono-substituted group chosen from pyrazolyl, imidazolyl, pyrazolinyl, imidazolinyl, pyrrolidinyl, phenothiazinyl, phenoxazinyl, phenazinyl, or acridinyl, wherein each substituent is independently chosen from a lengthening agent L, C1-C6 alkyl, C1-C6 alkoxy, phenyl, hydroxy, amino or halogen; and
(v) B and B\u2032 together form fluoren-9-ylidene, mono- or di-substituted fluoren-9-ylidene, or a saturated C3-C8 spiro-monocyclic hydrocarbon ring, saturated C7-C10 spiro-bicyclic hydrocarbon rings, saturated C7-C10 spiro-tricyclic hydrocarbon rings, said fluoren-9-ylidene substituents being selected from the group consisting of C1-C3 alkyl, C1-C3 alkoxy, fluoro and chloro.
4. The indeno-fused ring pyran compound of claim 1, wherein,
(A) Ring-A is selected from unsubstituted aryl and substituted aryl;
(B) for Q\u2032\u2033, each Ra is independently selected from hydrogen and an alkyl group having from 1 to 6 carbon atoms, and Rb is selected from a perfluorinated alkyl group having from 1 to 6 carbon atoms;
(c) R1 for each i, and R2 for each t, are each independently selected from,
(a) \u2014C(O)X24, wherein X24 is chosen from hydroxy, C1-C6 alkyl, C1-C6 alkoxy, phenyl that is unsubstituted or mono-substituted with C1-C6 alkyl or C1-C6 alkoxy, amino that is unsubstituted, mono- or di-substituted with at least one of C1-C6 alkyl, phenyl, benzyl, and naphthyl;
(b) \u2014OX7 and \u2014N(X7)2; wherein X7 is chosen from,
(i) hydrogen, C1-C6 alkyl, C1-C6 acyl, phenyl(C1-C6)alkyl, mono(C1-C6)alkyl substituted phenyl(C1-C6)alkyl, mono(C1-C6)alkoxy substituted phenyl(C1-C6)alkyl; C1-C6 alkoxy(C1-C6)alkyl; C3-C5 cycloalkyl; mono(C1-C6)alkyl substituted C3-C5 cycloalkyl, C1-C6 haloalkyl, allyl, benzoyl, mono-substituted benzoyl, naphthoyl or mono-substituted naphthoyl, wherein each of said benzoyl and naphthoyl substituents are independently chosen from C1-C3 alkyl, and C1-C3 alkoxy,
(ii) \u2014CH(X8)X9, wherein X8 is chosen from hydrogen or C1-C6 alkyl; and X9 is chosen from \u2014CN, \u2014CF3, or \u2014COOX10, wherein X10 is chosen from hydrogen or C1-C6 alkyl, and
(iii) \u2014C(O)X6, wherein X6 is chosen from hydrogen, C1-C12 alkoxy, phenoxy that is unsubstituted, mono- or di-substituted with C1-C6 alkyl or C1-C6 alkoxy, an aryl group that is unsubstituted, mono- or di-substituted with C1-C3 alkyl or C1-C3 alkoxy, an amino group that is unsubstituted, mono- or di-substituted with C1-C3 alkyl, and a phenylamino group that is unsubstituted, mono- or di-substituted with C1-C3 alkyl or C1-C3 alkoxy;

(c) nitrogen containing ring represented by Formula i,
wherein, each \u2014Y\u2014 is independently chosen for each occurrence from \u2014CH2\u2014, \u2014CH(R13\u2032)\u2014, \u2014C(R13\u2032)2\u2014, \u2014CH(aryl)-, \u2014C(aryl)2-, and \u2014C(R13\u2032)(aryl)-, and Z is \u2014Y\u2014, \u2014O\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014SO2\u2014, \u2014NH\u2014, \u2014N(R13\u2032)\u2014, or \u2014N(aryl)-, wherein each R13\u2032 is independently a lengthening group L, or C1-C20 alkyl, each aryl is independently phenyl or naphthyl, m is an integer 1, 2 or 3, and p is an integer 0, 1, 2, or 3, provided that when p is 0, Z is \u2014Y\u2014;

(d) a group represented by Formula ii or iii,
wherein X14, X15, and X16 are independently chosen for each occurrence from hydrogen, C1-C6 alkyl, or phenyl or X14 and X15 together form a ring of 5 to 7 carbon atoms; p is an integer chosen from 0, 1, or 2, and X17 is independently chosen for each occurrence from C1-C6 alkyl, C1-C6 alkoxy, or halogen;
(e) immediately adjacent R1 groups, and immediately adjacent R2 groups, in each case independently together form a group represented by Formula vii, viii, or ix,
\u2003wherein,
(i) W and W\u2032 are independently chosen for each occurrence from \u2014O\u2014, \u2014N(X7)\u2014, \u2014C(X14)\u2014, and \u2014C(X17)\u2014,
(ii) wherein X14 and X15 are independently chosen for each occurrence from hydrogen, C1-C6 alkyl, phenyl or naphthyl, or X14 and X15 together form a ring of 5 to 7 carbon atoms; and X17 is independently chosen for each occurrence from C1-C6 alkyl, C1-C6 alkoxy, or halogen, and
(iii) q is an integer chosen from 0 to 3;

(f) a lengthening agent L represented by the following formula,
\u2014(S)c-(Q1-(S2)d)d\u2032-(Q2-(S3)e)e\u2032-(Q3-(S4)f)f\u2032\u2014S5\u2014P
\u2003wherein,
(i) each Q1, Q2, and Q3 is independently chosen for each occurrence from, a divalent group chosen from, an unsubstituted or a substituted aromatic group, an unsubstituted or a substituted alicyclic group, an unsubstituted or a substituted heterocyclic group, and mixtures thereof, wherein substituents are chosen from, a group represented by P, liquid crystal mesogens, halogen, poly(C1-C18 alkoxy), C1-C18 alkoxycarbonyl, C1-C18 alkylcarbonyl, C1-C18 alkoxycarbonyloxy, aryloxycarbonyloxy, perfluoro(C1-C18)alkoxy, perfluoro(C1-C18)alkoxycarbonyl, perfluoro(C1-C18)alkylcarbonyl, perfluoro(C1-C18)alkylamino, di-(perfluoro(C1-C18)alkyl)amino, perfluoro(C1-C18)alkylthio, C1-C18 alkylthio, C1-C18 acetyl, C3-C10 cycloalkyl, C3-C10 cycloalkoxy, a straight-chain or branched C1-C18 alkyl group that is mono-substituted with cyano, halo, or C1-C18 alkoxy, or poly-substituted with halo, and a group comprising one of the following formulae: -M(T)(t-1) and -M(OT)(t-1), wherein M is chosen from aluminum, antimony, tantalum, titanium, zirconium and silicon, T is chosen from organofunctional radicals, organofunctional hydrocarbon radicals, aliphatic hydrocarbon radicals and aromatic hydrocarbon radicals, and t is the valence of M,
(ii) c, d, e, and f are each independently chosen from an integer ranging from 0 to 20, inclusive; and each S1, S2, S3, S4, and S5 is independently chosen for each occurrence from a spacer unit chosen from,
(1) \u2014(CH2)g\u2014, \u2014(CF2)h\u2014, \u2014Si(Z\u2032)2(CH2)g\u2014, \u2014(Si(CH3)2O)h\u2014, wherein each Z\u2032 is independently selected from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl, and aryl; g is independently chosen for each occurrence from 1 to 20; h is a whole number from 1 to 16 inclusive;
(2) \u2014N(Z)\u2014, \u2014C(Z)\u2550C(Z)\u2014, \u2014C(Z)\u2550N\u2014, \u2014C(Z\u2032)\u2014C(Z\u2032)\u2014 or a single bond, wherein Z is independently chosen for each occurrence from hydrogen, C1-C18 alkyl, C3-C10 cycloalkyl and aryl, and Z\u2032 is independently chosen for each occurrence from C1-C18 alkyl, C3-C10 cycloalkyl and aryl; and
(3) \u2014O\u2014, \u2014C(O)\u2014, \u2014C\u2261C\u2014, \u2014N\u2550N\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014S(O)(O)\u2014, \u2014(O)S(O)\u2014, \u2014(O)S(O)O\u2014, \u2014O(O)S(O)O\u2014, or straight-chain or branched C1-C24 alkylene residue, said C1-C24 alkylene residue being unsubstituted, mono-substituted by cyano or halo, or poly-substituted by halo;

provided that when two spacer units comprising heteroatoms are linked together the spacer units are linked so that heteroatoms are not directly linked to each other, and
provided that when S1 and S5 are linked to Formula II and P, respectively, they are linked so that two heteroatoms are not directly linked to each other;
(iii) P is chosen from: hydroxy, amino, C2-C18 alkenyl, C2-C18 alkynyl, azido, silyl, siloxy, silylhydride, (tetrahydro-2H-pyran-2-yl)oxy, thio, isocyanato, thioisocyanato, acryloyloxy, methacryloyloxy, 2-(acryloyloxy)ethylcarbamyl, 2-(methacryloyloxy)ethylcarbamyl, aziridinyl, allyloxycarbonyloxy, epoxy, carboxylic acid, carboxylic ester, acryloylamino, methacryloylamino, aminocarbonyl, C1-C18 alkyl aminocarbonyl, aminocarbonyl(C1-C18)alkyl, C1-C18 alkyloxycarbonyloxy, halocarbonyl, hydrogen, aryl, hydroxy(C1-C18)alkyl, C1-C18 alkyl, C1-C18 alkoxy, amino(C1-C18)alkyl, C1-C18 alkylamino, di-(C1-C18)alkylamino, C1-C18 alkyl(C1-C18)alkoxy, C1-C18 alkoxy(C1-C18)alkoxy, nitro, poly(C1-C18)alkyl ether, (C1-C18)alkyl(C1-C18)alkoxy(C1-C18)alkyl, polyethyleneoxy, polypropyleneoxy, ethylenyl, acryloyl, acryloyloxy(C1-C18)alkyl, methacryloyl, methacryloyloxy(C1-C18)alkyl, 2-chloroacryloyl, 2-phenylacryloyl, acryloyloxyphenyl, 2-chloroacryloylamino, 2-phenylacryloylaminocarbonyl, oxetanyl, glycidyl, cyano, isocyanato(C1-C18)alkyl, itaconic acid ester, vinyl ether, vinyl ester, a styrene derivative, main-chain and side-chain liquid crystal polymers, siloxane derivatives, ethyleneimine derivatives, maleic acid derivatives, fumaric acid derivatives, unsubstituted cinnamic acid derivatives, cinnamic acid derivatives that are substituted with at least one of methyl, methoxy, cyano and halogen, or substituted or unsubstituted chiral or non-chiral monovalent or divalent groups chosen from steroid radicals, terpenoid radicals, alkaloid radicals and mixtures thereof, wherein the substituents are independently chosen from C1-C18 alkyl, C1-C18 alkoxy, amino, C3-C10 cycloalkyl, C1-C18 alkyl(C1-C18)alkoxy, fluoro(C1-C18)alkyl, cyano, cyano(C1-C18)alkyl, cyano(C1-C18)alkoxy or mixtures thereof, or P is a structure having from 2 to 4 reactive groups or P is an unsubstituted or substituted ring opening metathesis polymerization precursor; and
(iv) d\u2032, e\u2032 and f\u2032 are each independently chosen from 0, 1, 2, 3, and 4, provided that a sum of d\u2032+e\u2032+f\u2032 is at least 1; and

(g) a group B as described hereinafter;

(D) R3 and R4 are each independently selected from hydrogen, C1-C8 alkyl, C1-C8 haloalkyl, and C3-C7 cycloalkyl, or R3 and R4 together form a spiro substituent selected from a substituted or unsubstituted spiro-carbocyclic ring containing 3 to 6 carbon atoms; and
(E) B and B\u2032 are each independently selected from,
(i) C1-C6 alkyl, C3-C5 cycloalkyl, C1-C6 haloalkyl and benzyl that is unsubstituted or mono-substituted with at least one of C1-C3 alkyl and C1-C3 alkoxy;
(ii) \u2014CH(CN)2 and \u2014CH(COOX1)2, wherein X1 is chosen from hydrogen, C1-C6 alkyl that is unsubstituted or mono-substituted with phenyl, phenyl(C1-C3)alkyl that is mono-substituted with C1-C3 alkyl or C1-C3 alkoxy, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C3 alkyl and C1-C3 alkoxy; and lengthening agent L;
(iii) \u2014CH(X2)(X3), wherein,
(1) X2 is chosen from at least one of a lengthening agent L, C1-C6 alkyl, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C3 alkyl and C1-C3 alkoxy; and
(2) X3 is chosen from at least one of \u2014COOX1, \u2014COX1, \u2014COX4, and \u2014CH2OX5, wherein: X4 is chosen from at least one of morpholino, piperidino, amino that is unsubstituted, mono- or di-substituted with C1-C3 alkyl, and an unsubstituted, mono or di-substituted group chosen from phenylamino and diphenylamino, wherein each substituent is independently chosen from C1-C3 alkyl or C1-C3 alkoxy; and X5 is chosen from hydrogen, a lengthening agent L, \u2014C(O)X2, C1-C6 alkyl that is unsubstituted or mono-substituted with (C1-C6)alkoxy or phenyl, phenyl(C1-C12)alkyl that is mono-substituted with (C1-C6)alkoxy, and an aryl group that is unsubstituted, mono- or di-substituted, wherein each aryl substituent is independently chosen from C1-C3 alkyl and C1-C3 alkoxy;
(iv) an unsubstituted, mono-, di-, or tri-substituted aryl group; 9-julolidinyl; or an unsubstituted, mono- or di-substituted heteroaromatic group chosen from pyridyl, furanyl, benzofuran-2-yl, benzofuran-3-yl, thienyl, benzothien-2-yl, benzothien-3-yl, dibenzofuranyl, dibenzothienyl, carbazoyl, benzopyridyl, indolinyl, or fluorenyl; wherein each substituent is independently chosen for each occurrence from,
(1) a lengthening agent L;
(2) \u2014C(O)X6;
(3) aryl, haloaryl, C3-C7 cycloalkylaryl, and an aryl group that is mono- or di-substituted with C1-C12 alkyl or C1-C12 alkoxy;
(4) C1-C6 alkyl, C3-C5 cycloalkyl, C3-C5 cycloalkyloxy(C1-C6)alkyl, aryl(C1-C6)alkyl, aryloxy(C1-C6)alkyl, mono- or di-(C1-C6)alkylaryl(C1-C6)alkyl, mono- or di-(C1-C6)alkoxyaryl(C1-C6)alkyl, haloalkyl, and mono(C1-C6)alkoxy(C1-C6)alkyl;
(5) C1-C6 alkoxy, C3-C5 cycloalkoxy, cycloalkyloxy(C1-C6)alkoxy, aryl(C1-C6)alkoxy, aryloxy(C1-C6)alkoxy, mono- or di-(C1-C6)alkylaryl(C1-C6)alkoxy, and mono- or di-(C1-C6)alkoxyaryl(C1-C6)alkoxy;
(6) aminocarbonyl, aminocarbonyl(C1-C18)alkylene, amino, mono- or di-alkylamino, diarylamino, piperazino, N\u2014(C1-C18)alkylpiperazino, N-arylpiperazino, aziridino, indolino, piperidino, morpholino, thiomorpholino, tetrahydroquinolino, tetrahydroisoquinolino, pyrrolidyl, hydroxy, acryloxy, methacryloxy, and halogen;
(7) \u2014OX7 or \u2014N(X7)2; and
(8) an unsubstituted or mono-substituted group chosen from pyrazolyl, imidazolyl, pyrazolinyl, imidazolinyl, pyrrolidinyl, phenothiazinyl, phenoxazinyl, phenazinyl, or acridinyl, wherein each substituent is independently chosen from a lengthening agent L, C1-C3 alkyl, C1-C3 alkoxy, phenyl, hydroxy, amino or halogen; and
(v) B and B\u2032 together form fluoren-9-ylidene, adamantylidene, bornylidene, norbornylidene or bicyclo(3.3.1)nonan-9-ylidene.
5. The indeno-fused ring pyran compound of claim 4, wherein said indeno-fused ring pyran compound is represented by the following Formula IIa,
IIa
wherein t is selected from 0 to 4.
6. The indeno-fused ring pyran compound of claim 5, wherein Position-12 of said indeno-fused ring pyran compound is substituted with hydrogen, and Q\u2032\u2033 is \u2014CN.
7. The indeno-fused ring pyran compound of claim 5, wherein i is at least 1, Position-12 has R1 bonded thereto, and Q\u2032\u2033 is selected from \u2014N3, \u2014C(O)ORa, \u2014C(O)Ra, \u2014C\u2261C\u2014Ra, \u2014C(Ra)\u2550C(Ra)(Ra), \u2014OC(O)Ra, \u2014OC(O)ORa, \u2014SRa, and \u2014OS(O2)Rb.
8. A photochromic composition comprising:
(a) the indeno-fused ring pyran compound of claim 1; and
(b) an organic material selected from a polymer, an oligomer, a monomer, and combinations of two or more thereof.
9. The photochromic composition of claim 8, wherein said polymer is selected from polycarbonate, polyamide, polyimide, poly(meth)acrylate, polycyclic alkene, polyurethane, poly(urea)urethane, polythiourethane, polythio(urea)urethane, polyol(allyl carbonate), cellulose acetate, cellulose diacetate, cellulose triacetate, cellulose acetate propionate, cellulose acetate butyrate, polyalkene, polyalkylene-vinyl acetate, poly(vinylacetate), poly(vinyl alcohol), poly(vinyl chloride), poly(vinylformal), poly(vinylacetal), poly(vinylidene chloride), poly(ethylene terephthalate), polyester, polysulfone, polyolefin, copolymers thereof, and combinations thereof.
10. The photochromic composition of claim 9 further comprising at least one additive selected from dyes, alignment promoters, photoinitiators, thermal initiators, polymerization inhibitors, solvents, light stabilizers, heat stabilizers, mold release agents, rheology control agents, leveling agents, free radical scavengers, and adhesion promoters.
11. A photochromic coating composition comprising:
(a) the indeno-fused ring pyran compound of claim 1;
(b) a film forming composition selected from a curable resin composition, a thermoplastic resin composition, and combinations thereof; and
(c) optionally a solvent composition.
12. A photochromic article comprising the indeno-fused ring pyran compound of claim 1.
13. The photochromic article of claim 12, wherein said photochromic article is an optical element selected from at least one of, an ophthalmic element, a display element, a window, a mirror, packaging material, an active liquid crystal cell element, and a passive liquid crystal cell element.
14. The photochromic article of claim 13, wherein said ophthalmic element is selected from corrective lenses, non-corrective lenses, contact lenses, intra-ocular lenses, magnifying lenses, protective lenses, and visors.
15. The photochromic article of claim 13, wherein said display element is selected from screens, monitors, and security elements.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method for killing or inhibiting growth of microbial cells comprising contacting the microbial cells with an antimicrobial peptide, wherein the antimicrobial peptide is encoded by a polynucleotide which hybridizes under high stringency conditions with (i) nucleotides 145 to 270 of SEQ ID NO:1, (ii) the cDNA sequence contained in nucleotides 1 to 270 of SEQ ID NO:1, or (iii) the complementary strand of (i) or (ii), wherein the high stringency conditions are defined as prehybridization and hybridization at 42\xb0 C. in 5\xd7SSPE, 0.3% SDS, 200 mgml sheared and denatured salmon sperm DNA, and 50% formamide, following standard Southern blotting procedures for 12 to 24 hours, followed by washing three times each for 15 minutes using 2\xd7SSC, 0.2% SDS at 65\xb0 C.
2. The method of claim 1, wherein the antimicrobial peptide is encoded by a polynucleotide which hybridizes under very high stringency conditions with (i) nucleotides 145 to 270 of SEQ ID NO:1, (ii) the cDNA sequence contained in nucleotides 1 to 270 of SEQ ID NO:1, or (iii) the complementary strand of (i) or (ii), wherein the very high stringency conditions are defined as prehybridization and hybridization at 42\xb0 C. in 5\xd7SSPE, 0.3% SDS, 200 \u03bcgml sheared and denatured salmon sperm DNA, and 50% formamide, following standard Southern blotting procedures for 12 to 24 hours, followed by washing three times each for 15 minutes using 2\xd7SSC, 0.2% SDS at 70\xb0 C.
3. A method for killing or inhibiting growth of microbial cells comprising contacting the microbial cells with an antimicrobial peptide, wherein the antimicrobial peptide has at least 90% identity with amino acids 1 to 42 of SEQ ID NO:2.
4. The method of claim 3, wherein the antimicrobial peptide has at least 95% identity with amino acids 1 to 42 of SEQ ID NO:2.
5. The method of claim 3, wherein the antimicrobial peptide has at least 96% identity with amino acids 1 to 42 of SEQ ID NO:2.
6. The method of claim 3, wherein the antimicrobial peptide has at least 97% identity with amino acids 1 to 42 of SEQ ID NO:2.
7. The method of claim 3, wherein the antimicrobial peptide has at least 98% identity with amino acids 1 to 42 of SEQ ID NO:2.
8. The method of claim 3, wherein the antimicrobial peptide has at least 99% identity with amino acids 1 to 42 of SEQ ID NO:2.
9. The method of claim 3, wherein the antimicrobial peptide comprises amino acids 1 to 42 of SEQ ID NO:2.
10. The method of claim 3, wherein the antimicrobial peptide consists of amino acids 1 to 42 of SEQ ID NO:2.

1. A composition for therapeutic use as a wound cover, comprising (i) epithelial cells derived from allogenic or autologous epidermis and (ii) a biopolymer membrane polymer selected from the group consisting of polylactic acid (PLA), polyglycolic acid (PGA) and polylactic-polyglycolic acid copolymer (PLGA).
2. The composition of claim 1, wherein the epithelial cells are present as a monolayer on the biopolymer membrane.
3. The composition of claim 2, wherein said monolayer is a sub-confluent monolayer.
4. The composition of claim 3, wherein said monolayer is at least 20% confluent.
5. The composition of claim 4, wherein said monolayer is at least 50% confluent.
6. The composition of claim 1, wherein the epithelial cells are keratinocyte cells.
7. The composition of claim 6, wherein the keratinocyte cells are keratinocyte stem cells.
8. The composition of claim 1, wherein the epithelial cells are transient amplifying cells.
9. The composition of claim 6, wherein the keratinocyte cells are present on the biopolymer membrane in a sub-confluent monolayer.
10. The composition of claim 6, wherein the keratinocyte cells comprise cells capable of further proliferation.
11. The composition of claim 6, wherein the keratinocyte cells comprise undifferentiated cells.
12. The composition of claim 1, wherein at least 90% of the epithelial cells are actively proliferating keratinocytes.
13. The composition of claim 1, wherein said cells retain substantial viability on the wound cover for at least 72 hours after application to a wound.
14. The composition of claim 1 wherein said biopolymer membrane is selected from biodegradable, biocompatible natural or synthetic material.
15. The composition of claim 1 wherein the biopolymer membrane selected from the group consisting of polylactic acid (PLA), polyglycolic acid (PGA) and polylactic-polyglycolic acid copolymer (PLGA) has a molecular weight of at least 50,000 Da.
16. A process for preparing the composition of claim 1 comprising the steps of:
a) isolating keratinocyte cells from allogenic or autologous epidermis;
b) preparing a cell suspension comprising the isolated keratinocyte cells;
c) expanding the keratinocyte cells;
d) optionally, cryopreserving the keratinocyte cells;
e) optionally, thawing the keratinocyte cells;
f) seeding the keratinocyte cells onto a biopolymer membrane;
g) expanding the keratinocyte cells into a sub-confluent monolayer on the biopolymer membrane; and
h) transporting the biopolymer membrane using a transport device comprising transport media.
17. The process of claim 16, wherein the keratinocytes cells are seeded onto biopolymer membrane sheets comprising PLA, at a cell concentration of 0.10\xd7106 to 0.5\xd7106cm.2.
18. The process of claim 16, wherein the wound cover is transferred to a transport device made of polycarbonate.
19. The process of claim 16, wherein the transport media comprises carbon dioxide enriched media.
20. A method of treating a wound in an individual comprising application of the composition of claim 1 to said wound in the individual, whereby said application is effective for the treatment of such wound.
21. The method of claim 20, wherein said wound is selected from the group consisting of:
a) a post-operative wound;
b) a burn;
c) a diabetic ulcer;
d) a bed sore; and
e) a traumatic injury.
22. The method of claim 20, wherein said individual is human.
23. A composition comprising a wound cover comprising a sub-confluent monolayer of keratinocyte cells and a biopolymer membrane.
24. A composition comprising a wound cover comprising a monolayer of undifferentiated keratinocyte cells on a biopolymer membrane.
25. A wound cover composition comprising (1) a sub-confluent monolayer of keratinocyte cells comprising undifferentiated cells and (2) a biopolymer membrane, wherein the monolayer is on the biopolymer membrane.
26. A method for treating a wound in a subject, comprising using a biopolymer membrane as a delivery system, and delivering to the wound a sub-confluent monolayer of keratinocyte cells comprising undifferentiated cells.
27. A kit for treating a wound, wherein the kit comprises (1) a wound cover comprising (a) a sub-confluent monolayer of keratinocyte cells comprising undifferentiated cells and (b) a biopolymer membrane, wherein the monolayer is on the biopolymer membrane; and (2) a transport device.
28. A composition comprising a wound cover comprising a monolayer of proliferating basal epithelial cells on a biopolymer membrane.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method for controlling read data buffering, comprising:
performing core operations in response to a receipt of a read command from a master controller;
determining which of either an internal or external communication buffer of one data storage node of one or more data storage nodes that is to forward information to said master controller, wherein said determining is based upon constraints and contents of one or more communication buffers of said one or more storage nodes; and
forwarding information from said internal or external communication buffer to said master controller.
2. The method of claim 1 wherein said forwarding information from said internal or external communication buffer comprises placing a burst of data from a data storage node located further away from said master controller than a data storage node located nearer said master controller between bursts of data sent to said master controller from said data storage node located nearer said master controller.
3. The method of claim 1 wherein said determining comprises determining if data exists in an internal communication buffer of a data storage node located nearest said master controller, and forwarding data to said master controller if it is determined that data exists in said internal communication buffer of said data storage node located nearest said master controller.
4. The method of claim 1 wherein said determining comprises determining if data is ready to be sent to said master controller by an internal read of a data storage node located nearest said master controller, and storing this data in an internal read buffer of said data storage node located nearest said master controller at the next available entry.
5. The method of claim 4 wherein said determining comprises determining if a data storage node located further away from said master controller than said data storage node that is located nearest said master controller is sending data to said data storage node located nearest said master controller, and storing this data in an external communication buffer of said data storage node located nearest said master controller at the next available entry, if it is determined that said data storage node located further away from said master controller than said data storage node located nearest said master controller is sending data to said data storage node located nearest said master controller.
6. The method of claim 1 wherein said determining comprises determining if data exists in an external communication buffer of a data storage node located nearest said master controller, and sending data to said master controller in a first in first out (FIFO) manner from said external communication buffer if it is determined that data exists in said external communication buffer of said data storage node located nearest said master controller.
7. The method of claim 1 wherein said determining is based on an algorithm that selects external traffic over internal traffic in a static decision and prioritizes data from further data storage nodes over data from data storage nodes that are nearer.
8. A data storage system that includes data buffering control, comprising:
one or more data storage nodes for storing information, wherein each of said one or more data storage nodes includes one or more communication buffers; and
a master controller coupled to said one or more data storage nodes for controlling a flow of information from said one or more data storage nodes to said master controller based upon constraints and contents of one or more communication buffers of a data storage node that is coupled to said master controller, wherein based on said constraints and said contents, a communication buffer of one of said one or more data storage nodes is selected to send information to said master controller.
9. The storage system of claim 8 wherein said controlling said flow of information from said one or more data storage nodes to said master controller comprises placing a burst of data from a data storage node located further away from said master controller than a data storage node located nearest said master controller between bursts of data sent to said controller from said data storage node that is located nearest to said master controller.
10. The storage system of claim 8 wherein said controlling said flow of information from said one or more data storage nodes comprises adjusting the timing of an issuance of a read command to be executed earlier or later based upon a determined latency.
11. The storage system of claim 8 wherein said controlling said flow of information from said one or more data storage nodes comprises determining if data exists in an internal communication buffer of a data storage node that is coupled nearest to said master controller, and sending data to said master controller if it is determined that data exists in said internal communication buffer of said storage node nearest to said master controller.
12. The storage system of claim 11 wherein said controlling said flow of information from said one or more data storage nodes comprises determining if data is ready to be sent to said master controller by an internal read of a data storage node that is coupled nearest to said master controller, and storing this data in an internal communication buffer of said data storage node coupled nearest to said master controller at the next available entry.
13. The storage system of claim 12 wherein said controlling said flow of information from said one or more data storage nodes comprises determining if a data storage node that is coupled further from said master controller is sending data to said data storage node that is coupled nearest to said master controller, and storing this data in an external communication buffer of said data storage node that is coupled nearest to said master controller at the next available entry, if it is determined that said data storage node that is coupled further from said master controller is sending data to said data storage node that is coupled nearest to said master controller.
14. The method of claim 8 wherein said controlling said flow of information from said one or more data storage nodes comprises determining if data exists in an external communication buffer of said data storage node that is coupled nearest to said master controller, and sending data to said master controller in a first in first out (FIFO) manner if it is determined that data exists in said external communication buffer of said data storage node coupled nearest to said master controller.
15. The method of claim 8 wherein said controlling said flow of information is based on an algorithm that selects external data traffic over internal data traffic in a static decision and prioritizes data from data storage nodes located further from said master controller over data from data storage nodes that are located nearer said master controller.
16. A computer readable medium having computer-executable components comprising:
a read scheduling component for scheduling the timing of a read command sent from a master controller to one of one or more data storage nodes;
a read command communicating component for communicating a read command to said one of said one or more data storage nodes;
a read data buffer selection component for determining an internal or external communication buffer of one of said one or more data storage nodes that is to send information to said controller based upon constraints and contents of one or more communication buffers of one or more of said one or more data storage nodes; and
a data forwarding component for forwarding information from said internal or external communication buffer to said master controller.
17. The medium of claim 16 wherein said sending information from said internal or external communication buffer comprises placing a burst of data forwarded from a data storage node located further away from said master controller than a data storage node located nearer said master controller between bursts of data sent to said master controller from said data storage node located nearer said master controller.
18. The medium of claim 16 wherein said scheduling said timing of said read command comprises adjusting a read command to be executed earlier or later based upon a determined latency.
19. The method of claim 16 wherein said determining comprises determining if data exists in an internal communication buffer of a data storage node located nearest said master controller, and forwarding data to said controller if it is determined that data exists in said internal communication buffer of said node located nearest said master controller.
20. The method of claim 16 wherein said determining is based on an algorithm that selects external traffic over internal traffic in a static decision and prioritizes data from further data storage nodes over data from data storage nodes that are nearer.